Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Adverse effects of androgen-deprivation therapy in prostate cancer and their management

(2015) Handoo Rhee et al.   BJU INTERNATIONAL

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory

(2015) Mieke Van Hemelrijck et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

(2015) Cecilia Bosco et al.   PLoS One

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study

(2014) Magdalena Lycken et al.   EUROPEAN JOURNAL OF CANCER

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) A. Horwich et al.   ANNALS OF ONCOLOGY

Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

(2012) M. Van Hemelrijck et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden

(2011) Anders Berglund et al.   JOURNAL OF UROLOGY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer

(2008) Matthew R. Smith et al.   UROLOGY